此外标普全球当天公布的数据显示，11月美国商业活动扩张速度创四个月最快，服务业增长加快，同时 对经济前景的乐观情绪显著改善。以上因素推动美国三大股指集体收涨。其中，道指上涨1.08%，标普 500指数上涨0.98%，纳指上涨0.88%。 21日国际金价小幅上涨 全周累计下跌 当地时间周五，美联储货币政策前景依然牵动着市场神经。在多位美联储官员一系列鹰派表态引发市场 恐慌之后，被称为美联储"三号人物"的纽约联储银行行长威廉姆斯当天表示，当前劳动力市场疲软对经 济构成的威胁已经超过了通胀压力，他认为，美联储仍有进一步降息的空间。威廉姆斯的鸽派言论令市 场对于美联储的降息预期出现反转，交易员预计12月议息会议宣布降息25个基点的概率超过70%，投资 者担忧情绪得到安抚。 公司方面，美国制药公司礼来股价周五上涨1.57%，成为全球首家市值突破万亿美元的药企。据外媒报 道，受产能扩大以及减肥药表现突出等因素提振，礼来公司逐步获得了更多的市场份额，据高盛预计， 礼来减肥药口服版本有望在明年一季度上市，比预期更快。礼来与美国政府本月初达成协议，大幅削减 部分减肥药的价格，也将扩大其药品覆盖范围，这预示着将带来销量上的增长潜 ...

Market Overview - Major U.S. stock index futures are down, with Dow futures falling by 0.75%, S&P 500 futures down by 0.64%, and Nasdaq futures decreasing by 0.89% [1] - Technology stocks are experiencing a broad decline, with Apple down by 1.31%, Nvidia down by 1.68%, and Amazon down by 1.08% [1] Company-Specific News - Tesla's stock price target has been lowered by HSBC from $125 to $120, maintaining a "reduce" rating. The analyst cites aging product lineup, increased competition in China, the U.S., and Europe, and brand image issues as negative factors affecting Tesla's performance and future outlook. Tesla's stock is down by 1.71% [1] - Eli Lilly has filed lawsuits against four generic drug manufacturers for allegedly producing and selling unapproved generic versions of its weight loss and diabetes medications. A U.S. judge previously prohibited these manufacturers from producing such generics. Eli Lilly's stock is down by 0.64% [1] - Southwest Airlines announced plans to cut flights in the second half of the year due to declining domestic booking trends and will not reaffirm its profit guidance for 2025 and 2026. The stock is down by 2.82% [2] - IBM's stock fell by over 8% after the cancellation of 15 government contracts due to cost-cutting measures by the Department of Government Efficiency (DOGE), despite reporting better-than-expected earnings and revenue for Q1 2025 [2] - Morgan Stanley raised the stock price target for AT&T from $28 to $31, maintaining an "overweight" rating, following AT&T's Q1 2025 earnings report that exceeded expectations and the announcement of a $10 billion stock buyback plan [2] - Sanofi's Q1 revenue of $9.89 billion fell short of the expected $10.99 billion, leading to a decline in its stock by 1.04% [3] - Texas Instruments reported Q1 earnings per share of $1.28, surpassing the expected $1.06, with revenue of $4.1 billion exceeding the anticipated $3.91 billion. The stock rose by 4.04% [3]